Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma.
Published: 15 June 2020| Version 2 | DOI: 10.17632/kc7wmn3rcs.2
Contributor:
Juha RantalaDescription
Supplementary data files for Mäkelä et al. Supplementary data 1. Ex vivo drug screening results. Supplementary data 2. NGS profiling results for MISB18 urachal cancer cell line.
Files
Categories
Drug Screening, Rare Tumor